Fortis Healthcare Limited — Others, 20-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Fortis Healthcare Limited has announced a board meeting on the financial results for the quarter and half-year. The company has fully utilized the INR 1,550 Cr raised through non-convertible debentures for acquiring Agilus Diagnostics Limited, with auditors confirming no deviation in fund usage. This disciplined capital deployment supports Fortis’s acquisition strategy and assures shareholders of transparent and effective use of resources.